American College of Physicians: Internal Medicine — Doctors for Adults ®

Advertisement

ACP DiabetesMonthly

Welcome to this month's issue of ACP DiabetesMonthly, an update for internists published by the American College of Physicians.



In the News for the month of March 2014




Highlights

FDA finds no link between incretin-based drugs, pancreatic complications

Data do not support a causal association between incretin-based drugs and pancreatitis or pancreatic cancer, concluded a review by U.S. and European regulatory agencies. More...

Sulfonylurea as second-line therapy appeared to lower cost in a population-based model

Sulfonylurea as second-line therapy for glycemic control in type 2 diabetes appeared to yield similar outcomes and quality-adjusted life-years but led to lower costs and longer time to insulin dependence compared with a dipeptidyl peptidase-4 inhibitor, glucagon-like peptide-1 receptor agonist, and insulin, according to a recent study. More...

Elderly patients most likely to land in ED, get admitted for insulin-related hypoglycemia

Elderly patients are more likely than younger patients to land in the ED and be hospitalized for insulin-related hypoglycemia and errors, a new study found. More...


Test yourself

MKSAP quiz: Nocturnal hypoglycemia in type 1 diabetes

This month's quiz asks readers to evaluate a 21-year-old man with type 1 diabetes being seen in the office for a follow-up to a recent hospitalization. More...


From ACP InternistWeekly

Standard blood glucose targets are lower than HbA1c goals require

A recent study determined the pre- and postprandial blood glucose levels that should be targeted to reach a specific HbA1c goal in patients with type 1 or type 2 diabetes. More...


From ACP Journal Club

Review: In type 1 or type 2 diabetes, group medical visits improve HbA1c levels compared with usual care

A meta-analysis of 13 randomized, controlled trials of adults with type 1 or type 2 diabetes found that group medical visits improved HbA1c levels but not the other factors studied, which included blood pressure, body mass index, weight, cholesterol, triglycerides, and quality of life. More...


FDA update

New drug approved, meters recalled

Dapaglifozin (Farxiga), a new medication to treat type 2 diabetes, was recently approved by the FDA for use along with diet and exercise. More...


Keeping tabs

Spotlight on stroke risk

The effect of hyperglycemia on stroke risk was examined by several studies published in the past month. More...

Editorial note: ACP DiabetesMonthly will not be published next month due to Internal Medicine 2014, which will be held April 10-12.


Physician editor: David V. O'Dell, MD, FACP



Has Your Contact Information Changed?

To change your e-mail address or other contact information in our records, go here or call 800-523-1546, ext. 2600 (M-F, 9 a.m. - 5 p.m. ET).

About Your Subscription

You are receiving this newsletter as a benefit of your ACP membership. To unsubscribe, simply send a blank e-mail to leave-105814-17003158N@acpnews.org.

ACP DiabetesMonthly is a monthly newsletter produced by the staff of ACP Internist. Please forward any comments or suggestions to acpinternist@acponline.org.

ACP respects your privacy and will not sell, lease or share your e-mail address with any other organization. The College will only use e-mail for the purpose of conducting College business and for communicating with College members.

Copyright © by American College of Physicians.

Test yourself

A 63-year-old man is evaluated for pleuritic left-sided anterior chest pain, which has persisted intermittently for 1 week. The pain lasts for hours at a time and is not provoked by exertion or relieved by rest but is worse when supine. He reports transient relief with acetaminophen and codeine and occasionally when leaning forward. He has had a low-grade fever for 3 days, without cough or chills. Medical history is significant for acute pericarditis 7 months ago. Following a physical exam and electrocardiogram, what is the most appropriate management?

Find the answer

Have questions about the new ABIM MOC Program?

Have questions about the new ABIM MOC Program?

ACP explains the ABIM requirements and offers many free solutions to earn MOC points.

One Click to Confidence - Free to members

One Click to Confidence - Free to members ACP Smart Medicine is a new, online clinical decision support tool specifically for internal medicine. Get rapid point-of-care access to evidence-based clinical recommendations and guidelines. Plus, users can easily earn CME credit. Learn more